Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia

This study has been completed.
Sponsor:
Collaborator:
Landsteiner Foundation Blood Research (LSBR), Amsterdam
Information provided by:
Sanquin
ClinicalTrials.gov Identifier:
NCT00138736
First received: August 29, 2005
Last updated: August 29, 2007
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given